UltraGreen Cardiac Technologies
UltraGreen Cardiac Technologies delivers cloud-based Holter monitoring services to cardiology practices using disposable wireless ECG biosensors powered by LifeSignals technology and the UbiqVue cloud portal to streamline cardiac diagnostics globally.
- Company typePrivate
- Founded-
- HeadquartersLong Island, United States
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
What UltraGreen Cardiac Technologies does
UltraGreen Cardiac Technologies operates as a trading name of UltraGreen.ai Private Limited, an Irish-registered private limited company headquartered at IDA Business Park, Athlone, Co-Westmeath, Ireland, with additional offices in Long Island, New York (USA) and on MacPherson Road in Singapore. The company delivers cloud-based Holter monitoring services to cardiology practices and cardiac care clinics, positioning its offering as a replacement for conventional reusable wired Holter recorders through disposable wireless biosensors and a unified cloud workflow platform.
Its product suite centers on the UbiqVue Portal, a HIPAA-compliant cloud platform that manages the full Holter workflow from patient onboarding through analysis to final report delivery and is accessible via iOS, Android, and desktop. Two disposable 2-channel ECG biosensors power data capture: the UbiqVue 1AXe (28g, IP24 ingress protection, defibrillation-proof, up to 5-day monitoring with patient-activated event recording, 244.14 and 976.56 samples per second at 16-bit resolution) and the UbiqVue 2AYe (32g, IP24 water protection, WLAN and BLE 5.2 connectivity with WPA2-PSK/CCMP and AES-CCM 128-bit encryption, up to 5-day battery life). The biosensor layer is sourced from LifeSignals under a core strategic technology partnership that the company describes as a global initiative.
UltraGreen runs a sales-led go-to-market targeting enterprise cardiology practices, with pricing not publicly disclosed and demand generation centered on website-driven demo requests, a LinkedIn presence, and a resources library of brochures, news, and an explainer video. Revenue is generated through a recurring Holter monitoring service combined with consumable disposable biosensors delivered to practices, with global distribution supported through the LifeSignals partnership across the Americas, Europe, and Asia-Pacific. No funding rounds, M&A activity, leadership team disclosures, named customers, or regulatory actions are present in the available data.
UltraGreen Cardiac Technologies firmographics
Firmographics- Name
- UltraGreen Cardiac Technologies
- Legal name
- UltraGreen.ai Private Limited
- Website
- https://ultragreencardiac.com
- Company type
- Private
- Operating status
- Operating
- Short description
- UltraGreen Cardiac Technologies delivers cloud-based Holter monitoring services to cardiology practices using disposable wireless ECG biosensors powered by LifeSignals technology and the UbiqVue cloud portal to streamline cardiac diagnostics globally.
- Ownership category
- akta.pro rank
UltraGreen Cardiac Technologies industry classification
Industry- Product category
- Cardiac Monitoring Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders) (HLAHACAB)
- akta.pro secondary industry
- Cardiology Telemedicine Platforms (HLALAGAB)
Keywords
Where UltraGreen Cardiac Technologies is headquartered
LocationHeadquarters
- HQ city
- Long Island
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
UltraGreen Cardiac Technologies business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations
Revenue model
- Holter Monitoring Service: UltraGreen Cardiac Technologies provides a complete cloud-based Holter ECG monitoring analysis and reporting service to cardiology practices. The service eliminates device logistics burden and enables cloud-based Holter report delivery. Revenue appears to be generated through a subscription or service model where cardiology practices pay for monitoring services, potentially including device costs, data processing, and report delivery.
- Disposable Biosensor Hardware: The company provides disposable wireless biosensors (UbiqVue 1AXe and 2AYe) for Holter monitoring. These single-use devices are included as part of the monitoring service offering and represent a consumable/hardware component of the revenue model.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
UltraGreen Cardiac Technologies product offering
Product offeringCore offering
UltraGreen Cardiac Technologies delivers a cloud-based Holter ECG monitoring solution for cardiology practices, comprising disposable wireless biosensors (UbiqVue 1AXe and 2AYe) and the UbiqVue Portal for patient onboarding, data analysis, and report delivery. The system eliminates device return logistics, supports up to five days of continuous monitoring, and provides same-day preliminary report turnaround.
Product overview
UltraGreen Cardiac Technologies offers a unified Holter monitoring solution comprising the UbiqVue Portal (cloud-based workflow management platform) and two disposable wireless biosensor products (UbiqVue 1AXe and UbiqVue 2AYe). The system provides end-to-end cardiac monitoring from patient onboarding through report delivery, with the UbiqVue Holter System integrating wireless biosensors, data recovery, analysis, and report management into a single cloud-based platform powered by LifeSignals Biosensor Technology.
Differentiator
Problem solved
Functional benefit
Products and services
- UbiqVue Portal A cloud-based cardiac monitoring web portal that streamlines the Holter monitoring workflow from patient onboarding to final report delivery, including instant report access with rhythm summaries, electronic signature capability, patient and exam management, customizable dashboards, and device logistics tracking. It is HIPAA-compliant and accessible via iOS, Android, and desktop.
- UbiqVue 1AXe Biosensor A disposable 2-channel ECG biosensor (105mm x 94mm x 12mm, 28g) with IP24 ingress protection, supporting up to 5 days of Holter monitoring with a 7-day memory cache and patient-activated event recording at 244.14 and 976.56 samples per second with 16-bit resolution; defibrillation-proof design with lithium-manganese dioxide battery.
- UbiqVue 2AYe Biosensor A disposable wireless 2-channel ECG biosensor (116mm x 91mm x 15.5mm, 32g) with IP24 water protection, WLAN (IEEE 802.11b, WPA2-PSK/CCMP security) and BLE 5.2 (AES-CCM 128-bit encryption) connectivity, up to 5 days battery life, and 5-day memory cache.
- UbiqVue Holter System A complete cloud-based Holter ECG monitoring analysis and reporting system comprising wireless biosensors, data recovery, data analysis, and patient and Holter report management capabilities, powered by LifeSignals Biosensor Technology.
- UltraGreen Monitoring Service A cardiac monitoring service for cardiology practices that eliminates device logistics and enables cloud-based Holter report delivery within hours rather than days.
Quantifiable outcome
- Same-day preliminary report turnaround (within hours, not days)
- +2 more outcomes
Companies that use UltraGreen Cardiac Technologies
Customer profileSegments1 record
Ideal customer profiles1 record
UltraGreen Cardiac Technologies technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
UltraGreen Cardiac Technologies partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- LifeSignalscoreUltraGreen Cardiac Technologies has launched a strategic partnership with LifeSignals to expand global access to advanced wearable cardiac monitoring biosensors. LifeSignals provides the proprietary biosensor technology that powers UltraGreen's Holter monitoring solution, enabling wireless, disposable ECG monitoring devices. This partnership supports UltraGreen's scalable and responsive approach to ambulatory cardiac monitoring, combining LifeSignals' biosensor technology with UltraGreen's cloud-based UbiqVue Portal and clinical workflow expertise.
Scale indicators1 record
Recent moves5 records
Expansion highlights6 records
UltraGreen Cardiac Technologies competitors and assessment
Company assessmentDirect peers
- iRhythm Technologies: iRhythm's Zio suite is a direct competitor in ambulatory cardiac monitoring, offering a wireless patch ECG (Zio Monitor and Zio AT) with cloud-based reporting for cardiology practices—the same core use case UltraGreen addresses with its UbiqVue Holter biosensors and portal.
- Compumedics: Compumedics manufactures and sells Holter ECG recorders and analysis software (e.g., Somte, Cardio series) used by cardiology practices—directly comparable hardware-and-software Holter workflow to UltraGreen's offering.
- Spacelabs Healthcare (Holter Systems): Spacelabs offers Holter recorders and analysis software sold to cardiology practices and hospitals, directly overlapping with UltraGreen's Holter ECG monitoring, analysis, and reporting service.
- Preventice Solutions (now Boston Scientific): Preventice's BodyGuardian suite provides wireless ambulatory ECG monitoring with patch sensors and a cloud platform for cardiology practices, closely mirroring UltraGreen's disposable biosensor plus cloud portal approach.
Broad incumbents
- GE Healthcare (MUSE / Holter): GE Healthcare provides established Holter monitoring solutions and the MUSE cardiology information system used by many cardiology practices; it is a broad incumbent that UltraGreen must displace or coexist with on workflow and reporting.
- Hillrom / Baxter (BardyDx CAM patch): Baxter (via Hillrom, which acquired Bardy Diagnostics) offers the CAM patch, a wireless, disposable cardiac monitor with cloud reporting—a near-identical disposable ECG model to UltraGreen's UbiqVue biosensors within a broader hospital equipment portfolio.
- Philips (BioTelemetry / Cardiac Monitoring): Philips, via BioTelemetry, offers MCT, Holter, and event monitoring services for cardiology practices with a broad connected cardiac portfolio; it competes with UltraGreen on Holter and ambulatory monitoring workflows while serving a wider hospital enterprise ecosystem.
Emerging players
- HeartBeam: HeartBeam is developing a credit-card-sized ECG device with cloud-based cardiac diagnostics for ambulatory use; it shares UltraGreen's wireless, cloud-delivered ECG theme and cardiology practice target, though it focuses on synthesized 12-lead rather than multi-day Holter.
- AliveCor: AliveCor provides consumer and clinician-facing ECG solutions (KardiaMobile, KardiaCloud) for ambulatory rhythm assessment; it overlaps with UltraGreen's wireless ECG and cloud-reporting model in cardiology workflows, though focused more on spot ECG than multi-day Holter.
Others
- LifeSignals: LifeSignals is UltraGreen's core technology partner and supplies the proprietary biosensor hardware powering UbiqVue; as the upstream enabler of UltraGreen's offering, it is a directly comparable wearable ECG platform but operates one tier up in the stack.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
UltraGreen Cardiac Technologies social profiles
Digital presenceUltraGreen Cardiac Technologies compliance and trust
Trust signalCompliance1 record
UltraGreen Cardiac Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
UltraGreen Cardiac Technologies leadership team
Management profileNumber of profiles
UltraGreen Cardiac Technologies funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
UltraGreen Cardiac Technologies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about UltraGreen Cardiac Technologies
What does UltraGreen Cardiac Technologies do?
UltraGreen Cardiac Technologies delivers a cloud-based Holter ECG monitoring solution for cardiology practices, comprising disposable wireless biosensors (UbiqVue 1AXe and 2AYe) and the UbiqVue Portal for patient onboarding, data analysis, and report delivery. The system eliminates device return logistics, supports up to five days of continuous monitoring, and provides same-day preliminary report turnaround.
Is UltraGreen Cardiac Technologies a public or private company?
UltraGreen Cardiac Technologies is a private company. It is classified as unknown and is currently operating.
When was UltraGreen Cardiac Technologies founded?
UltraGreen Cardiac Technologies was founded in -1.
Where is UltraGreen Cardiac Technologies based?
UltraGreen Cardiac Technologies is headquartered in Long Island, United States, in the North America region.
How does UltraGreen Cardiac Technologies make money?
Two revenue lines are on record. Holter Monitoring Service is the primary driver. The others are disposable Biosensor Hardware.
Who are UltraGreen Cardiac Technologies's main competitors?
Direct peers on record are iRhythm Technologies, Compumedics, Spacelabs Healthcare (Holter Systems) and Preventice Solutions (now Boston Scientific). Broad incumbents are GE Healthcare (MUSE / Holter), Hillrom / Baxter (BardyDx CAM patch) and Philips (BioTelemetry / Cardiac Monitoring). Emerging players are HeartBeam and AliveCor. LifeSignals is listed as an others.
Does UltraGreen Cardiac Technologies have an API?
No public API is recorded for UltraGreen Cardiac Technologies.
What industry is UltraGreen Cardiac Technologies in?
UltraGreen Cardiac Technologies's product category is Cardiac Monitoring Devices. Its primary akta.pro industry code is HLAHACAB, Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders), with a secondary code of HLALAGAB, Cardiology Telemedicine Platforms. Its NAICS code is 334510 and its SIC code is 3845.